Contraceptive pharmaceutical preparation
Preparation, for oral contraception, comprises dienogest (1.5 or 2 mg) and ethynylestradiol (0.015-0.020 (preferably 0.015) mg) together with one or more carriers, to at least 21 days dosing unit of the 28-days menstrual cycle. ACTIVITY : Contraceptive. MECHANISM OF ACTION : None given.
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Preparation, for oral contraception, comprises dienogest (1.5 or 2 mg) and ethynylestradiol (0.015-0.020 (preferably 0.015) mg) together with one or more carriers, to at least 21 days dosing unit of the 28-days menstrual cycle. ACTIVITY : Contraceptive. MECHANISM OF ACTION : None given. |
---|